|
MXI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.04201108747293E-14 |
| Normal-vs-Stage2 |
6.95780000281587E-09 |
| Normal-vs-Stage3 |
4.2854608750531E-13 |
| Normal-vs-Stage4 |
1.11709996808429E-09 |
| Stage1-vs-Stage2 |
5.711800E-01 |
| Stage1-vs-Stage3 |
1.540420E-01 |
| Stage1-vs-Stage4 |
3.235200E-01 |
| Stage2-vs-Stage3 |
6.583000E-01 |
| Stage2-vs-Stage4 |
7.536800E-01 |
| Stage3-vs-Stage4 |
9.315400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.339310E-03 |
| Normal-vs-Asian |
7.95060017821925E-10 |
| Caucasian-vs-AfricanAmerican |
3.341800E-02 |
| Caucasian-vs-Asian |
5.326600E-01 |
| AfricanAmerican-vs-Asian |
1.933750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.33888513795955E-13 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
7.249800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.55759857736848E-11 |
| Normal-vs-Age(41-60Yrs) |
1.22124532708767E-15 |
| Normal-vs-Age(61-80Yrs) |
6.25199891857164E-12 |
| Normal-vs-Age(81-100Yrs) |
2.968100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.266800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.216400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.497800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.931200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.183000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.430000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.609900E-02 |
| Classical-VS-Follicular |
2.67560000044575E-07 |
| Classical-VS-Other |
4.466000E-01 |
| Classical-VS-Normal |
1.04100061903978E-11 |
| Tall-VS-Follicular |
1.99539999967691E-07 |
| Tall-VS-Other |
4.715700E-02 |
| Tall-VS-Normal |
2.31359376101636E-12 |
| Follicular-VS-Other |
3.996000E-01 |
| Follicular-VS-Normal |
1.810140E-04 |
| Other-VS-Normal |
1.369900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.47690756793872E-13 |
| Normal-vs-N1 |
6.26909635315087E-11 |
| N0-vs-N1 |
8.901800E-02 |
|
|
